A Study Evaluating the Safety of Cal-1 (LVsh5/C46) Drug Product in HIV-1 Infected Patient With High Risk Lymphoma
Status:
Recruiting
Trial end date:
2024-01-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and the feasibility, and the success of
engraftment of the introduction of Cal-1 gene-transduced haematopoietic cell populations (Ttn
and HSPCtn) in patients with HIV-1-related high-risk lymphoma.